Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-052-9 | CAS number: 77-73-6
Exxon Biomedical Sciences (2004) is a GLP compliant, ready biodegradability study on DCPD/Codimer Concentrate, which has been read across to DCPD. The study, which follows OECD guideline 301F, showed 0% biodegradation in 28 days and therefore DCPD is considered to be not readily biodegradable.
This is supported by the results of a MITI study, used in the OECD SIDS but not available for review. The SIDS Initial assessment (1997) identified a MITI report which indicated that under aerobic conditions dicylopentadiene (DCPD) showed 0% degradation after 2 weeks and classed the substance as not readily biodegradable.
For DCPD the Biowin 3 prediction of ultimate degradation time is 2.90 and the probabilities of fast degradation under Biowin 2 and 6 are 0.76 and 0.23 respectively, with an overall prediction of not readily biodegradable. BioHCwin V1.01 predicts the half life of dicylopentadiene to be 21.4 days.
The results from both QSAR indicate that DCPD is expected not to be readily biodegradable. On the basis of the available data and the QSAR prediction, DCPD is considered to be P but not vP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again